Ocaliva

DRUG3 trials

Sponsors

Intercept Pharmaceuticals Inc., University of Leipzig, Universitaire Ziekenhuizen KU Leuven

Conditions

HealthyPBCPrimary Biliary CholangitisPrimary Biliary Cholangitis (PBC)

Phase 2

A Phase 2, Double-Blind, Randomized, Parallel Group Study Evaluating the Efficacy, Safety, and Tolerability of Obeticholic Acid Administered in Combination with Bezafibrate in Subjects with Primary Biliary Cholangitis Who Had an Inadequate Response or Who Were Unable to Tolerate Ursodeoxycholic Acid

CompletedCTIS2024-513762-18-00

Intercept Pharmaceuticals Inc.Primary Biliary Cholangitis (PBC)

Start: 2019-09-20End: 2025-10-14Target: 65Updated: 2025-07-18

Unknown Phase

Prospective, Multicenter Cohort Study on Primary Biliary Cholangitis

University of LeipzigPBC, Primary Biliary Cholangitis

Start: 2019-09-19End: 2024-03-31Target: 1200Updated: 2023-06-07

The Effect of Obeticholic Acid in Healthy Volunteers

Universitaire Ziekenhuizen KU LeuvenHealthy

Start: 2022-08-22End: 2023-07-22Target: 12Updated: 2023-02-23